Table 2 |
||||
|
Studies evaluating the risk of coronary heart disease in systemic lupus erythematosus |
||||
|
[Reference] (year) |
Study design |
SLE definition |
n |
Estimated risk |
|
|
||||
|
[11] (1997) |
Prospective cohort |
ACR criteria for SLE |
498 |
5-fold risk for MI 50-fold risk in ages 35 to 44 years |
|
[86] (1999) |
Retrospective cohort |
Rheumatologist diagnosis |
8,742 |
2.27-fold risk for MI 3.8-fold risk for chronic heart failure |
|
[12] (2001) |
Retrospective cohort |
Rheumatologist diagnosis |
296 |
17.0-fold risk for CVD 10.1-fold risk for MI 7.9-fold risk for stroke |
|
[87] (2004) |
Cross-sectional, prospective |
ACR criteria for SLE |
202 (cross-sectional), 47 (prospective) |
1.4-fold risk for CHD 0.6-fold risk for stroke 8.5% CHD events 10% stroke follow up |
|
[88] (2004) |
Case control |
Physician diagnosis |
770 |
1.46 risk for MI |
|
|
||||
|
ACR, American College of Rheumatology; CHD, coronary heart disease; CVD, cardiovascular disease; MI, myocardial infarction; SLE, systemic lupus erythematosus. |
||||
|
Full et al. Arthritis Research & Therapy 2009 11:217 doi:10.1186/ar2631 |
||||